Community Spirit Acupuncture London

Wimbledon Acupuncture Clinic



Community Spirit is an affordable acupuncture clinic in South Wimbledon, London. We are a short walk from Colliers Wood tube station on the Northern Line.

Clinics run:
Every Tuesday from 2.00pm to 6.30pm

All Saints Centre
44 All Saints Road
SW19 1BX

07791 414 440 Sue

Map & Directions

Because of our location close to the Northern Line stations of Colliers Wood and South Wimbledon, we are easy to get to from Tooting Bec, Tooting Broadway, Mitcham and Morden, as well as Wimbledon itself. Follow the link above for location, directions and travel information.

British Acupuncture Council logo 

ACMAC logo

[migraine and acupuncture]

Drugs for Migraine Prophylaxis (Prevention)

The table below outlines the uses and side effects of the most common preventative migraine treatment drugs

(Back to main article: Migraines, Drugs, Acupuncture and other Therapies)

Please note: The information below has been compiled from the British National Formulary 57, the Journal of Neurological Sciences, and the Medical Journal of Australia. Consult a qualified physician before making changes or additions to your drug regimen.

Drug Group

Drug Name (& Recommended Use)

Side Effects


Beta Blockers

Proparnolol (40-120mg twice daily).

Metoprolol (50mg twice daily).


Fatigue, postural dizziness, hypotension, bradycardia, excessive dreams, cold extremities.

Starts with low dose, increased over time. Taper dose at end of treatment (danger of reflex tachycardia).

Should not be used in hemiplegic migraine or in frequently recurring migraine with aura.

Contraindications: asthma, chronic lung disease, diabetes, hypoglycaemia, bradycardia, hypotension, Raynaud's, peripheral vascular disease, depression.

Calcium Channel Antagonists

Flunarizine (10mg/day).

Verapamil (240mg/day).

Nimodipine (120mg/day).

Constipation, fluid retention in the ankles, cardiac dysfunction, hypotension, drowsiness, dizziness.

Flunarizine only: depression, weight gain, secondary Parkinson's.

Some studies show benefits vs. placebo, others show little or no effectiveness.

Flunarizine should be used with caution amongst elderly patients.

Tricyclic Antidepressants

Amitriptyline (10-75mg/night)

Weight gain, morning drowsiness, dry mouth constipation, blurred vision, sexual disturbance, urinary retention

Useful when migraine presents with depression, anxiety, sleep disorders.

Contraindications: cardiac arrhythmias, glaucoma, urinary retention.

Use with caution amongst elderly.

Membrane Stabilisers (Anticonvulsants)

Sodium valporate (800-1500mg/day).

Weight gain, drowsiness, hair loss, hepatic/haematological disfunction, pancreatitis, PCOS.

Use very cautiously with women of childbearing age. Contraindicated for infants, hepatic disease.

Topiramate (25-100mg twice daily).

Renal stones, weight loss, paraesthesis, glaucoma, cognitive disfunction (fully reversible), metabolic acidosis

Dose must be gradually increased to avoid side effects.

Divalproex sodium (500-1500mg/day)

Weight gain, brittle hair, tremor, endocrine effects in young women.

Gabapentin (900-2400mg/day)

Occasional weight gain, drowsiness.

Well tolerated, no significant drug-drug interations.

General side effects associated with anticonvulsants as a class: weight gain, hair loss, tremor, GI upset, sedation, asthenia, dizziness, cognitive change.

Most anticonvulsants contraindicated in pregnancy

Serotonergic Agents

Methysergide (1-4mg/day)

Retroperitoneal and periplural fibrosis (extended use), nausea, muscle cramps, weight gain, abdominal pain, diarrhoea, psychiatric symptoms, dizziness, drowsiness, paraesthesia.

Should be discontinued for 3-4 weeks after every 6 months of therapy.

Contraindicated in coronary artery disease, peripheral vascular disease, hypertension, pregnancy, peptic ulcer, phlebitis, lung disease, liver disease, kidney disease.


  1. British National Formulary 56. (2008). London: BMJ Group & RPS Publishing.
  2. Rapoport, A.M. (2008). Acute and prophylactic treatments for migraine: present and future. Neurological Sciences, 29 (S1), S110-S122. .
  3. Stark, R.J., & Stark, C.D. (2008). Migraine prophylaxis. Medical Journal of Australia, 189 (5), 283-288.